BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma and Multiple Myeloma

Clinical trial NCT07771361 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07771361
Sponsor: Luminary Therapeutics
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma Refractory/ Relapsed Multiple Myeloma Refractory Multiple Myeloma in Relapse Non-Hodgkin Lymphoma, B-cell Non-Hodgkin Lymphoma Non-Hodgkin Lymphoma (NHL)Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma Multiple Myeloma in Remission

Start date: 2026-12-01
Primary completion: 2030-12-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.